We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ultrasound Molecular Imaging Advances Noninvasive Diagnosis of NASH

By HospiMedica International staff writers
Posted on 23 Jan 2024

Non-alcoholic fatty liver disease (NAFLD), recently rebranded as metabolic dysfunction-associated fatty liver disease (MAFLD), encompasses a range of conditions from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH). More...

The most reliable method for diagnosing NASH has been invasive liver biopsy, evaluating histopathological features like liver steatosis, ballooning, and lobular inflammation. Despite its accuracy, liver biopsy has limitations, including sampling bias, low acceptance among patients, and the risk of complications. Existing clinical imaging methods like ultrasound and magnetic resonance imaging (MRI) can detect or quantify liver steatosis but fall short in distinguishing between NASH and NAFLD. This underscores the need for noninvasive markers that can effectively indicate the histologic characteristics of NASH.

Researchers from Sun Yat-sen University (Guangdong, China) have advanced a novel approach known as sequential ultrasound molecular imaging (USMI). for identifying NASH by visualizing hepatic steatosis and inflammation. In this study, they employed specific microbubbles (MBs) targeting CD36 and ICAM-1 separately, rather than using dual-targeted MBs. This strategy enables the differentiation of the sources of the signals, whether stemming from steatosis or inflammation and identifies which pathological change is predominant. CD36 is associated with liver steatosis, while increased ICAM-1 levels are linked to the progression of liver inflammation. Therefore, quantitatively visualizing hepatic CD36 and ICAM-1 could provide critical insights into the severity of hepatic steatosis and inflammation. This research marks a significant stride towards achieving the ultimate goal of developing a reliable, noninvasive method for NASH detection.

“As a noninvasive diagnostic tool, this strategy has the potential to assist in clinical therapeutic decision-making and contribute to drug development for NASH,” said Tinghui Yin, lead author of the study. “Furthermore, among various sequential USMI-based diagnostic models, the serial testing model showed high diagnostic performance in detecting NASH, with 95% sensitivity, 97% specificity, 95% positive predictive values, 97% negative predictive values and 96% accuracy.”

Related Links:
Sun Yat-sen University


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gynecological Examination Chair
arco-matic
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.